Ignite Creation Date:
2025-12-25 @ 4:35 AM
Ignite Modification Date:
2026-01-26 @ 1:17 AM
Study NCT ID:
NCT05627518
Status:
COMPLETED
Last Update Posted:
2025-04-03
First Post:
2022-11-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Relative Bioavailability of Linaprazan for the Test Formulation vs. Reference Formulation
Sponsor:
Cinclus Pharma Holding AB
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CX842A2106
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None